Ensysce Biosciences, Inc. (ENSC) Q1 2024 Earnings
ENSC·Reported May 10, 2024·Before market open
Ensysce Biosciences, Inc. reported Q1 2024 revenue of $305.7K, missed analyst consensus of $400.0K by $94.3K. Diluted EPS came in at $-8.25, beat the $-13.49 consensus by $5.24.
Revenue
$305.7Kmissed by $94.3K
Consensus: $400.0KDiluted EPS
$-8.25beat by $5.24
Consensus: $-13.49
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Ensysce Biosciences, Inc.'s Q1 2024 earnings report.
Ensysce Biosciences, Inc. (ENSC) reported Q1 2024 earnings on May 10, 2024 before market open.
Ensysce Biosciences, Inc. reported revenue of $305.7K and diluted EPS of $-8.25 for Q1 2024.
Revenue missed the consensus estimate of $400.0K by $94.3K. EPS beat the consensus estimate of $-13.49 by $5.24.
You can read the 10-Q periodic report (0001493152-24-018718) directly on SEC EDGAR. The filing index links above go to sec.gov.